Clinical Trials Browser

Phase 3 × dostarlimab × Head & Neck × Clear all

NCT06256588 2025-09-25

JADE

Phase 3 Recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms